Internal Medicine, Endocrinology, Diabetes, & Metabolism · Martinsburg, WV
NPI
1043396229
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
176 Health Care Ln, Suite B
Martinsburg, WV, 25401
Phone (304) 260-1060
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,261 services
Medicare patients, 2024
184
Average age 71
Drug cost, 2024
$1.7M
4,809 prescriptions
Company payments, 2025
$1,958
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip J Ryan was code 99214 (office e&m - established), 435 times for 165 patients. In total Philip J Ryan billed 1,261 services in 14 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 435 | 165 | $76.49 | $33K |
| 83036 Blood Count | Office | 339 | 126 | $9.52 | $3,227 |
| 81003 Clinical Chemistry | Office | 313 | 123 | $2.19 | $684 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 49 | 40 | $10.67 | $523 |
| 99215 Office E&M - Established | Office | 33 | 33 | $99.54 | $3,285 |
| 99205 Office E&M - New | Office | 29 | 29 | $142.56 | $4,134 |
| 90656 Vaccine Product | Office | 18 | 18 | $21.90 | $394 |
| G0008 Administration of influenza virus vaccine | Office | 18 | 18 | $24.50 | $441 |
By year: 2022 $57K for 1,191 services; 2023 $47K for 1,201 services; 2024 $47K for 1,261 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 339 | 126 | $9.52 | $3,227 |
| 81003 Clinical Chemistry | 313 | 123 | $2.19 | $684 |
Medicare prescription drug claims, 2024
In 2024, the drug Philip J Ryan prescribed most often to Medicare patients was Pioglitazone Hcl, with 501 prescriptions and refills. In total Philip J Ryan wrote 4,809 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pioglitazone Hcl Generic | 501 | 1,331 | 146 | $8,684 |
| Rosuvastatin Calcium Generic | 235 | 659 | 68 | $6,895 |
| Mounjaro Tirzepatide | 224 | 418 | 50 | $442K |
| Atorvastatin Calcium Generic | 224 | 613 | 72 | $2,118 |
| Oseltamivir Phosphate Generic | 208 | 210 | 119 | $9,643 |
| Metformin Hcl Generic | 202 | 572 | 61 | $1,513 |
| Glimepiride Generic | 179 | 468 | 57 | $2,547 |
| Synthroid Levothyroxine Sodium | 135 | 331 | 39 | $13K |
| Premarin Estrogens, Conjugated | 132 | 284 | 38 | $61K |
| Trulicity Dulaglutide | 125 | 186 | 28 | $177K |
| Glyxambi Empagliflozin/Linagliptin | 101 | 272 | 30 | $158K |
| Testosterone Generic | 88 | 126 | 20 | $11K |
| Ozempic Semaglutide | 86 | 153 | 22 | $139K |
| Ezetimibe Generic | 75 | 219 | 25 | $2,550 |
| Jardiance Empagliflozin | 75 | 174 | 23 | $99K |
Brand drugs: 1,407 claims; generic drugs: 3,337 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philip J Ryan $1,958 ($1,958 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $329.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 9 | $329 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 12 | $241 |
| Lilly USA, LLC LLY | 11 | $238 |
| Abbvie Inc. ABBV | 13 | $197 |
| Abbott Laboratories ABT | 17 | $195 |
| Antares Pharma, Inc. | 5 | $143 |
| Novo Nordisk Inc NVO | 5 | $120 |
| Esperion Therapeutics, Inc. ESPR | 5 | $107 |
| Astellas Pharma US Inc 4503.T | 4 | $80.34 |
| Alvogen Inc | 2 | $47.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.